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Because of its interference with the formation of messenger ribonucleic acid, 
actinomycin D  has come to be regarded as a general inhibitor of protein syn- 
thesis. Under certain conditions, however, the drug has the opposite net effect 
and  appears to enhance protein synthesis. This paradoxical phenomenon has 
been examined in bacteria, rats, and many different mammalian culture systems 
(see DISCUSSION). The proteins most frequently studied have been various in- 
duced enzymes. One postulated explanation of this phenomenon is  that syn- 
thesis of the induced enzyme is modulated by an inhibitor normally appearing 
soon after enzyme induction and that under certain conditions inhibitor forma- 
tion may be selectively suppressed by acfinomycin. Clearly, isolation of the 
postulated  inhibitor  would  provide  the  most  convincing  evidence  for  this 
hypothesis. 
Under  certain  conditions  the  immune  response  also may  be  enhanced  by 
actinomycin. This paper describes both the inhibitory and enhancing effects of 
the drug on the secondary antibody response in rabbit lymph node cultures. 
The conditions found critical for enhancement in vitro, such as the timing and 
level of actinomycin D  treatment, are also those theoretically essential for the 
hypothesis described above. However, greater support for the hypothesis comes 
from our recovery in used culture medium of a nondialyzable inhibitor of anti- 
body synthesis. Various features of this macromolecule suggest that it is the 
postulated inhibitor. These studies thus imply a  control mechanism for anti- 
body synthesis not widely suspected by immunologists. 
Materials and Methods 
Michaelides and Coons (1) originated the idea of stimulating and following  the secondary 
antibody response in organ cultures of rabbit lymph node fragments. Briefly, their method 
involved priming a rabbit by a single set of injections with one or two antigens (e.g. bovine 
* This investigation was supported by grant  AI-06861 from the United States  Public 
Health Service.  A preliminary report has been published (Fed.  Pro¢. 27:317, 1968). 
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serum albumin and diphtheria toxoid). Several months later the popliteal nodes were asepti- 
cally removed and cut into small fragments. These were incubated for 2 hr in a  dilute solu- 
tion of the priming antigen(s), rinsed free of excess antigen in Hanks' solution, and then dis- 
tributed in plasma clots among tubes incubated in a roller drum. Eagle's medium containing 
25% normal rabbit serum was added to each tube and replaced every 3--4 days for several 
weeks. The media removed were refrigerated and subsequently titrated by the hemaggiutina- 
tion method with tanned sheep erythrocytes [Stavitsky's modification of the Boyden pro- 
cedure (2)]. 
Our modifications  of  this  technique,  used in  current  experiments  and described  in  previous 
papers (3-5),  include  the following:  (a) the development of a serum-free,  chemically  defined 
medium; (b) the replacement of  the  plasma clot  by a glass  wool pad overlying  the fragments 
in a Leighton tube,  thus fixing  them in position;  (c) the conversion  to stationary  cultures; 
(aT)  the control  of pH by gassing  individual  tubes  with 5% COS in air;  (e) the utilization  of 
other  lymph nodes,  such as  the  axillary,  auricular,  and cervical  nodes;  and  (.f)  the  use of  other 
antigens,  including  tetanus toxoid and ovalbumin. The several  modifications  not previously 
described  but  used in  experiments  of  this  paper  are  discussed  below  in  some detail. 
It  has  recently  been  determined that  the  osmolarity  of  the  medium considerably  influences 
the course and magnitude of the secondary response.  The optimal osmolarity  for use with 
rabbit  lymph node fragments is around 280 milllosmols/kg,  1 10% or so lower than that  of 
conventional  media and of those used in earlier  experiments.  Table I lists  the composition 
of  the  medium used in  the  present  studies  and outlines  its  preparation. 
For experiments with medium replacement every 3 days, 14 fragmcnts/ml medium per 
Leighton tube sufficed  to produce convenient titers.  In other  experiments,  in which the cul- 
ture  fluids  were  replaced  as often  as  every 2 hr  during  part  of  the  productive  phase,  as many 
as 39 fragments/ml medium per Leighton tube were used.  When such frequent  changes of 
medium were made, the media were preheated to 37°C, and the tubes,  while  outside  the in- 
cubator,  were kept at  37°C by enclosing  them in  a small  heating  pad. Still  other  experiments 
were pcrformed to  isolate  an  inhibitory  material  from large  volumes of  used culture  medium. 
Here  large  Leighton tubes (Be]]co  Glass,  Inc.,  Vineland,  N.J.)  were  employed, in  each of  which 
i00 fragments could be cultured.  The volume of medium added was kept around i mi/20 
fragments.  For  this  work  large  Leighton tubes (35 X  150  ram) were  preferable  to  Petri  dishes, 
because the rubber-stoppered  tubes  became infected  less  frequently  and did not require  the 
use of a COs incubator. 
In this  paper hemagglutination  data are  presented  in  one of  three  graphs.  The simplest  is 
the differential response graph, in which the ordinate indicates the average titer of medium 
removed from a group of cultures at a given time, and the abscissa, the times of the different 
medium changes. Typical differential response curves are presented in Fig.  1.  For certain 
kinetic studies, integral response curves reveal effects more dearly. On the ordinate of these 
graphs is plotted the cumulative sum of the average titers of successive medium changes for a 
group; the absdssa shows the time of the medium replacement. Examples are seen in Fig. 2. 
The third type of graph involves a dose-response curve like that in Fig. 4. Here the ordinate 
is a measure of antibody production by each group, and the abscissa,  the concentration of some 
agent whose effect on the antibody response is being measured.  Since each point of a  dose- 
response curve is derived from one differential  response curve,  this  graph  presents  many 
data in a condensed form. 
RESULTS 
Inhibition  by Actinomycin D  Treatment Begun during the Inductive Phase or 
during the Productive Phase.--The  inductive phase of the immune  response in 
1 C. T. Ambrose, unpublished results. TABLE I 
Components, Stock Solutions, and Sequence of Preparing Serum-Free Medium 
Components 
Initial water 
Glucose-salt solution 
Phenol red 
NaHCOa 
Eagle's 12 amino acids 
Glutamine 
5 accessory amino acids 
NaOH 
Eagle's "B" vitamins 
Vitamin BI~ 
Penicillin G, potassium 
salt 
Cormol (Solu-Cortef) 
[nsulin,  crystalline 
Final water 
Vo]mne 
Stock solutions: concentration,  of  Concentration 
commercial source, and  stock  in final medium 
storage temperature  soution 
added* 
ml 
Double-distiUed water  70 
Components added in the fol-  10  5 n~ glucose 
lowing  order  at  room  tem- 
perature  with  mixing  on  a 
magnetic  stirrer:  970  ml 
double-distilled water, 72.6 g 
NaCI,  9.0 g  glucose,  2.98  g 
KCI, 0.71 g Na2HPO4,0.17 
g  NaH~PO4.H~O,  2.03  g 
MgCI2"H20,  and  1.11  g 
CaCI~. Final volume is 1000 
ml (refrigerate) 
2.0 mg/ml (refrigerate)  O. 5  0.01 mg/ml 
500 m~ (room temperature)  2.0  10 m~ 
50X  MEM:~  ~mlno  acids  2.0  1 X 
(GIBCo.)§ (refrigerate) 
100X  L-glutamine,  200  mM  1.0  2ram 
(GIBCo.)  (freeze) 
10 n~ each of alauine, aspartie  1.0  0.1 mM 
acid,  glycine,  proline,  and 
serine  (Calbiochem)[[  (re- 
frigerate) 
1.0 N; add volume (x) sufficient  x 
to yield final pH of 7.3 
100X  MEM  vitamin solution  1.0  1 X 
(GIBCo.) (freeze) 
50 ~g/ml (Calbiochem)  1.0  0.5 ~g/ml 
(freeze) 
11,800 uuits/ml  =  7.08  0.5  59 units/ml = 
mg/ml ffi 20 n~ (Squibb)  35 pg/ml = 
(freeze)  0.1 n~ 
100/m (Upjohn) (freeze)  1.0  1.0/J~ 
2 mg/ml Insulin requires slight  1.0  0.5 un/t/ml = 
acidification for solubiliza-  20.  ~g/ml 
tion (Sigma)¶ (freeze) 
Double-distilled  water;  addl  (9--x) 
(9 -- x) ml final water 
Contri- 
bution 
to 
o~o- 
laxity 
m//ll- 
os.md.s/ 
kg 
0 
250 
0 
17 
13 
* The final volume here is 100 ml. 
:~ Minimal essential medium. 
§ Grand Island Biological Co., Grand Island, N. Y. 
II Calbiochem, Los Angeles, Calif. 
¶  Sigma Chemical Co., St. Louis, Mo. 
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vitro (days 0-9) is nearly 10 times more sensitive to inhibition by actinomycin 
D  than is the productive phase (days 9-21 or later). This differential sensitivity 
is illustrated by data in Fig. 1 and summarized in Table II. Graph A  of Fig. 1 
illustrates relative inhibition of the response when different concentrations of 
6000' 
5000' 
W 
4000' 
3000'  < 
t 
2000' 
o 
I000" 
oI 
Actinomycin  O  0.0026-0.08/.cM  [ 
3  3, 
A. 
none 
S  6  9  12  15  18  21  24 
DAY  OF  CULTURE 
Actin. D  0.0026-0.08~.M  [ 
9  i~ 
8.  0008 
none  A 
\a 
C 
:3  6  9  12  15  -18  21  24 
DAY OF  CULTURE 
FIO.  1. Inhibition by actinomycin D of the in vitro secondary antibody response depicted 
as the differential response. Rabbit lymph node cultures were maintained for 24 days; the 
medium of each tube was replaced every 3 days. The response of the untreated control group 
of cultures is duplicated in each graph of this figure and is labeled curve A in graph B. 
Graph A. Four groups of cultures were treated with actinomycin D starting on day 3, as 
indicated by the bar at the top of the graph. The micromolar concentrations of the drug used 
are indicated above the different response curves. 
Graph B. Four other groups of cultures were treated with actinomycin D starting on day 9, 
as indicated by the bar at the top of this graph. The micromolar drug concentrations used are 
marked above each curve. These responses are labeled curve B, C, D, and E. Another group 
was treated with 10/~M  puromycin starting on day 9; this response is labeled curve F. The curve 
B group became infected after day 18 and was terminated then. 
the drug were present in the medium, starting on day 3  during the inductive 
phase. The level of actinomycin D  in each treated culture was renewed every 3 
days when the medium was replaced. Under these conditions 0.0026/zx~ (0.0033 
#g/rnl) depressed the 24 hr response to 33 %  of the untreated control group of 
cultures. Higher concentrations of the drug reduced the response proportion- 
ately (See column A  of Table II). 
Graph B  of Fig. 1 shows the second part of this experiment, in which other 
cultures were treated with  the same levels of actinomycin D  starting 6  days CHARLES  T.  AMBROSE  1007 
later; that is, starting on day 9 early in the productive phase. The lower two 
levels of the drug appeared to produce enhancement before inhibition finally 
occurred--a phenomenon explored later in  this paper.  The two higher drug 
levels produced prompt inhibition. In this graph are also plotted the responses 
of the control group (curve A)  and of another group treated with 10 ~  (5.4 
/~g/ml) puromycin starting on day 9. After addition of puromycin the response 
was only 6 % that of the control group during the same period. This indicates 
that little antibody was released from these fragments after synthesis had been 
stopped. The greater susceptibility of the inductive phase to actinomycin D 
TABLE II 
Inhibition  by Actinomycin D of the Secondary Anffbody Response in Vitro; Influence of Drug 
Concentragon and of Drug Treatment Interval* 
Antibody formation 
Period of aetlnomycin D treatment  Days 3-24  Days 9-24 
Period of mathematical analysis  Da.~ ~_24  Days 3-12  Days 9-24 
Drug and level  ~)~  (9 ~]~s)  (9 ~S) 
None 
Actinomycin D,  0.0026/~r 
Actinomycin D,  0.008 g~ 
Actinomycin D,  0.026 g~ 
Actinomycin D,  0.08/~ 
Puromycin,  10.0/~r 
%  %  % 
loo~  loo§  lOOll 
33  63  102 
13  32  114 
4  11  46 
<i  i  21 
6 
* These data were derived from cultures whose average responses are graphed in Fig. 1. 
:~ The response  of untreated (control) cultures from day 3 to 24. 
§ The response of these same cultures for the 9-day period from day 3 to 12 (see graph A 
of Fig. 1). 
[I The response of other cultures in this same experiment  for the 9 day period from day 9 
to 18 (see graph B of Fig. 1). 
inhibition is apparent upon comparing columns B  and C  of Table II. When 
treatment began on day 3,  0.008 #~  reduced the response to 32 %  over the 
ensuing 9  days. But when treatment began on day 9, 0.008 #~ actinomycin 
permitted a 9 day response of 114%. At this time a level of the drug 10 times 
higher (0.08 ~)  was required to depress the response to a similar extent; that 
is, to 21% of the control group's response. 
In this culture system antibody production generally was constant for a week 
or more during the early productive phase. This feature of the secondary re- 
sponse in vitro is more apparent in Fig. 2, in which the differential responses of 
Fig. 1 B have been regraphed as integral, or cumulative, responses. Each curve 
is identified by a letter to facilitate comparison between Fig.  1 B  and Fig. 2. 
In Fig. 2 the linearity of the control group's response between days 6 and 21 is 1008  REGULATION  OF THE  SECONDARY  ANTIBODY  RESPONSE 
readily evident (curve A). Treatment with the different levels of actinomycin 
and  of puromycin starting  on day 9  (see solid arrow of each curve)  stopped 
antibody synthesis after varying intervals. 
The efficiency of inhibition by these drugs could be resolved more finely in 
cultures  whose  media were replaced  every few hours.  In Fig.  3  are  graphed 
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FIG. 2.  Inhibition by actinomycin D of the in vitro secondary antibody response, depicted 
as the integral (cumulative) response. The six differential responses drawn in graph B of Fig. 
1 and labeled A through F have been regraphed here as integral responses. The day of each 
medium change is indicated above the points drawn for curve A. The arrows pointing to day 
9 indicate when treatment  with  actinomycin D  (AD) or puromycin was commenced, and 
what concentration was used. 
cumulative responses between days 10 and  12 for cultures whose medium was 
replaced  every 4  hr.  For lack of space in Fig.  3,  the average response of the 
control group of five cultures is shown only for the first 36 hr, but this average 
response continued in a  precisely linear rate for the entire 52 hr studied.  The 
four  other  curves derived  from this  experiment have been  spaced  along the 
abscissa so that they do not  overlap; however, the intervals graphed are the 
same for all five curves. Different levels of actinomycin D  or puromycin were 
added  simultaneously to groups of quadruplicate  cultures  in  the  experiment; CHARLES  T.  AMBROSE  1009 
the  start  of  treatment  is  indicated  on  each  response  curve  by  the  arrow. 
Each subsequent medium replacement contained anew the starting level of the 
drug. From the graph of the average responses, the time required for synthesis 
of the first 50% of all antibody produced subsequent to the addition of a given 
level of each drug  was  estimated. This moment is termed in  this paper the 
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FiG.  3.  Termination  of the productive  phase in  vitro  by different concentrations  of ac- 
tinomycin D, The integral (cumulative) anti-tetanus toxoid (anti-TT) responses of five groups 
of cultures are depicted here for only the period of days 10-12. The arrows point to the same 
medium change for each group when their medium thereafter included actinomycin D (AD) 
(0.4, 2.0, or 10 pM) or puromycin (5 pz~). To the right of each arrow is noted the time in 
hours required for synthesis of the initial 50% of all antibody produced after inclusion of the 
inhibitor. 
"50% synthesis time." These times were 6, 3.6, and 2.8 hr for actinomycin D 
levels of 0.4, 2.0, and 10 #M, respectively. In this experiment, the 50% synthesis 
time for 5 #M (2.7/~g/ml) puromycin was also 2.8 hr. 
It is obvious from Figs. 2 and 3 that inhibition of antibody synthesis is faster 
with higher levels of actinomycin D. A  summary of data from seven experi- 
ments of this same design has been compiled in Fig. 4. The ordinate indicates 
the hours required for production of the initial 50%  of the antibody response 
subsequent to addition of a given drug level; the abscissa indicates the different I010  REGULATION  OF ~  SECONDARY  ANTIBODY  RESPONSE 
levels of actinomycin D  tested. Low levels of the drug (e.g., 0.016 #M) permitted 
50% synthesis times of 30-40 hr; in these experiments the media were replaced 
only daily or every 12 hr. Higher levels reduced the 50 %  synthesis time to a 
few hours; in these experiments the media were replaced more frequently--as 
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Fro. 4.  Termination of the productive phase in vitro by actinomycin D. The points plotted 
here were obtained from seven different experiments like that depicted in Fig. 3. Each point 
represents the time required for synthesis of the initial 50% of all antibody produced by a 
group of cultures after addition of a particular concentration of actinomycin D  to their me- 
dium. The variously shaped points refer to different experiments,  whose media were changed 
with the different frequencies listed in the figure. CHARLES  T. AMBROSE  1011 
often as every 3 hr. In different experiments with low levels of actinomycin D, 
there was a  wide spread in the 50% synthesis times. With increasing levels of 
the drug, however, this spread decreased, and the values became asymptotic to 
a line intersecting just below the 3 hr level of the ordinate. Since these concen- 
trations of acfinomycin D  presumably inhibit synthesis of new messenger RNA, 
there probably exists in these cultures a family of mRNA's with a half-life of 3 hr 
that is essential for antibody synthesis. The data do not indicate whether this 
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Fxo. 5. The enhancement of the secondary anti--diphtheria toxoid (anti-DT) response in 
vitro by 0.0025 ~M (0.0031 #g/m1) actinomycin D (AD). The period of treatment is indicated 
by the box (or boxes) above each graph. The reference response shown in graph A represents 
the average response of eight cultures not treated with the drug. The other graphs represent 
the average response of four cultures treated with the drug for 2 or 6 days, starting on day 6 
or day 8. To facilitate comparison of responses, the day 6 response is drawn  in  aU graphs 
as a solid circle, the day 8 response as a solid square, and the day 10 response as a solid tri- 
angle. 
mRNA is directly concerned with coding for immunoglobulin chains or is essen- 
tial for maintaining the antibody-producing cell itself. 
A ctinomycin D Enhancement of the Secondary Response In Vitro.--Treatment 
with low levels of actinomycin D  produced apparent enhancement of antibody 
synthesis in several early experiments (e.g. curves B  and C  in Fig.  1 B). This 
phenomenon was explored systematically in an experiment depicted in Fig. 5. 
Here the media were replaced every 2 days; actinomycin D  at 0.0025/~x~ (0.003 
#g/ml) was included in the medium of some cultures on day 6 or on day 8 for 
2 day or 6 day intervals. The reference response drawn in graph A  represents 
the average of eight cultures not treated with the drug. 
In graph B  (Fig. 5) is shown the response of cultures treated once with actino- 
mycin D  for 2 days, starting on day 6. Enhancement occurred between days 8 1012  ImGULArION  OF  THE  SECONDARY  ANTIBODY  RESPONSE 
and  10,  after  which  time  the  average  response  remained  at  a  plateau  50% 
higher than the average response of the control cultures during the same period. 
In graph C  is shown the effect of 6 day treatment with the medium containing 
the drug added successively on days 6, 8, and 10. No significant enhancement 
occurred. Instead there is evidence of inhibition after day 12, as if too prolonged 
treatment with actinomycin produced cumulative toxic effects. 
FIG. 6. The  enhancement  of the  secondary  anti-tetanus  toxoid  (anti-TT)  response  in 
vitro by actinomycin D (AD) added for 2 days at different times. The medium of each culture 
was replaced every 2 days. The reference response represents the average response of eight 
cultures not treated with the drug, whereas the other responses represent the average response 
of four cultures  similarly treated.  The reference curve has been transposed  as a gray back- 
ground to the other graphs in this figure. The 2 day period of actinomycin treatment coin- 
cides with the box at the top of the other graphs; the number beneath  each box denotes the 
day treatment began. The open boxes designate 2 day treatment which yielded no enhance- 
ment. The X-marked boxes indicate which responses were enhanced by the 2 day treatment. 
In  graph  D  (Fig.  5)  is  shown  the  response  of  cultures  treated  once  with 
actinomycin D  for 2 days, starting on day 8. A  striking enhancement occurred 
during the 2 day treatment period and continued during the following 2 days, 
reaching a  peak average response more than double that of the control group. 
In graph E  (Fig.  5)  is shown the effect of a  6  day treatment  with medium 
containing the drug added on days 8, 10, and 12. Enhancement occurred during 
the first 2  day treatment period; the response reached a  plateau  and then fell 
sharply,  again  giving the  impression  that  too prolonged  treatment  with  the 
drug caused a cumulative toxic effect. Not shown in Fig. 6, but also included in CHARLES  T.  AMBROSE  1013 
the experiment, was the effect of treatment with actinomycin for 2 days and for 
6 days starting on day 10. The responses closely duplicated those shown in Fig. 
5D andE. 
The period  of optimal enhancement by actinomycin D  was explored more 
thoroughly in the experiment shown in Fig. 6. In these cultures the media were 
replaced  every 2 days. The reference response drawn in the upper left-hand 
graph depicts  the average  response of eight cultures not treated with actino- 
mycin D.  The other  graphs  show  the  average  responses  of  quadruplicate 
cultures treated at different  times for 2 days  with 0.01/~ (0.008 ~g/ml) actino- 
mycin D. The gray shaded area depicting the reference response has been trans- 
posed to the graphed responses of each actinomycin-treated  group. Before intro- 
duction of the drug, the average response of each treated group was very similar 
to the average response of the untreated reference group. 2 day treatment with 
actinomycin  D starting on day 0, 2, or 4 produced no apparent enhancement or 
inhibition. Nor was any temporally related enhancement  produced by treatment 
starting on day 16 (the lower right-hand graph). However, treatment for those 
2 day periods marked with a X  in the box at the top of each graph--that is, 
starting on day 6, 8, 10,  12, or 14--produced an enhancement in each group 
related precisely to the time when the drug was added to the cultures of that 
group. 
Several  experiments  already described  suggested  that  a  cumulative toxic 
effect  is produced by too prolonged  treatment with actinomycin D.  Fig.  7 
illustrates this observation.  The shaded areas in all graphs of this figure repre- 
sent the average  responses of eight untreated cultures.  The other curves  are 
average  responses  of quadruplicate cultures treated with different levels  of 
actinomycin  D for 2 or 10 days, starting on day 8. In each graph the drug level 
tested is listed, and the duration of treatment is indicated by the boxes at the 
top. The media of these cultures were replaced daily, so that actinomycin D 
was reintroduced into the culture a second time during the 2 day treatment 
schedule  (top  row  of graphs)  and  nine times during the  10  day treatment 
schedule  (bottom row of graphs). 
All levels of actinomycin  D tested (0.0025-0.01/~) produced a similar initial 
enhancement, with the peak responses being about double that of the untreated 
group.  In all treated groups  enhancement continued for 3 days, either as  a 
continually rising response or as an initial high rise with a narrow plateau. The 
responses then abruptly fell. The terminal descending curves  of most groups 
treated for only 2 days are superimposable on the descending limb of the refer- 
ence response, while the descending curves of those cultures treated for 10 days 
with levels  above  0.025 /~ soon  fall be/ow the corresponding  points of the 
reference response. Thus, in this experiment  (as in Fig. 5), continuous treat- 
ment with actlnomycin D  starting on day 8 produced an initial enhancement 
followed by inhibition. 1014  REGIYLATION OF THE  SECONDARY  ANTIBODY  RESPONSE 
~8 
=  -,.-,  8~ 
N 
N  B" ~ 
.'=8  ,? 
~  ~  . 
°~ CHARLES T.  AMBROSE  1015 
This is the only experiment  of several dozen in which enhancement was pro- 
duced with a level of actinomycin D as high as 0.01 g~r. In contrast are several 
other experiments  which showed no enhancement of antibody synthesis, even 
when a  wide  range of actinomydn D  levels was  used.  This variability en- 
countered in different experiments is probably related to the capacity of actino- 
mycin D to bind nonspecifically to glass and specifically to cellular breakdown 
products, such as effete chromatin and DNA. 14 rabbit lymph node fragments 
release over 1 million ceils into the medium in the first 3 days of culture, half 
that  number  in  the  next  3  days,  and  proportionately smaller  numbers  in 
successive 3 day intervals. The fraction of these ceils which  die and release 
nudear breakdown products doubtless varies from experiment to experiment. 
Therefore it is not surprising  that experiments  occasionally fail to show en- 
hancement, since usually successful low levels of actinomycin D  may be re- 
duced to an ineffectual level by such extraneous binding. 
Recovery of an Inhibitor of the Immune Response from Tissue Culture Fluids.-- 
Several hypotheses have been offered to explain the paradoxical  enhancement 
of protein synthesis by low levels of actinomycin D  (see DlSCtrSSlOZ¢). One in 
particular was pursued with the present culture system. This was the hypothesis 
by Garren et al. (6) of a "repressor" which would affect translation and whose 
formation would be inhibited preferentially by actinomycin  D. Since actinomy- 
tin D produced enhancement in the present experiments only during the middle 
of the secondary response (see Fig. 6), an inhibitor was sought in medium re- 
moved from cultures during this middle period  of the response.  The assay 
system employed was an in vitro response to a different  antigen. Two controls 
for this experiment were pools removed during the early period of the response 
and also during the late period of the response. Fig. 8 depicts the scheme and 
results of this experiment. 
Media were saved from 52 tubes of an anti-BSA 2 experiment,  the secondary 
response of which is shown in graph A of Fig. 8. As soon as the culture medium 
had been removed from all cultures on a given day, it was pooled, centrifuged 
to remove suspended cells lost from the organ cultures,  and frozen. At the end 
of this experiment,  the media removed  on days 3 and 6 were thawed, pooled 
together, concentrated by dialysis against sucrose, dialyzed against a balanced 
salt solution, and incorporated into serum-free culture medium. The same pro- 
cedure was followed for pools of media removed on days 9 and 12, and also for 
those removed on days 15 and 18. These three 6 day pools were designated the 
"early," "mid," and  "late" pools.  The  concentration of the  noudialyzable 
material of these pools after incorporation into each of the three new media 
was  5.5-fold;  that is,  5.5  times that contained in the original  used medium 
pools. The anti-BSA in these pools did not cross-react with the assay system, 
2 Abbreviation  used in paper: AIM, antibody-inhibitory material; BSA, bovine serum al- 
bumin; R-RBC, rat erythroeytes; S-RBC, sheep erythroeytes. i 
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which  involved  cultures  producing  an anti-tetanus response.  The  reference 
response for these cultures is shown in graph B (Fig. 8); the 21 day antibody 
synthesis was taken as the 100% response in this assay part of the experiment. 
Medium containing the early anti-BSA  pool was added to cultures shown in 
graph C for the first 12 days, i.e. on days 0, 3, 6, and 9. No over-all inhibition 
or enhancement occurred,  and the 21 day response was 96% of the reference 
response. The medium containing the mid-anti-BSA pool was included during 
the same 12 day interval in cultures whose average response is shown in graph 
SOURCE  OF  INHIBITOR 
(anti-BSA) 
ASSAY  SYSTEM  FOR  INHIBITOR 
~,  (anti-TT) 
6000 
4000 
2000 
0 
Reference  response 
0  6  12  18 
1200"  i 
800 
400, 
ol 0/ 
,  ~,  I,,  ,I,  ~.,,  I,  I. 
early  mid  late 
J/ 
;a,,,0oo,  I j  I 
9~  49g 
0  6  12  18  0  6  12  18 
DAY  OF  CULTURE  (3 day intervals) 
late  pool  [ 
96~ 
0  6  12  18 
Fro.  8.  Recovery  of  an  inhibitor of  antibody  synthesis from  "used"  culture  medium 
(see the text). TT is tetanus toxoid. 
D. Here the 21 day response was depressed to 49 % of the reference response. 
Finally, medium containing the late anti-BSA pool was added to cultures whose 
average response  is shown  in graph E.  There was no effect on the over-all 
response of these cultures,  which yielded 96 % of the reference response. Thus 
the mid-anti-BSA pool  contained a  nondialyzable substance which  was  in- 
hibitory to the anti-tetanus toxoid response. The anti-BSA titer was higher in 
the late pool, which makes it unlikely that the nondialyzable inhibitor found 
in the mid pool was anti-BSA globulin. 
Similar levels of inhibition have been obtained with mid-pool  concentrates 
prepared from both anti-ovalbumin response in vitro and also other anti-BSA 
responses in vitro. No inhibitory effect has been found using media of cultures CHARLES  T.  AMBROSE  1017 
prepared  from a  primed rabbit which was not stimulated in vitro to give a 
secondary response. No inhibitory effect was recovered in media from spleen 
cultures stimulated to give a secondary response, but this failure may be related 
to the poor response produced by these cultures in vitro. Inhibitory concen- 
trates from mid-anti-BSA pools have also been prepared by lyophilization and 
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Fro. 9. Inhibition  of the productive  phase by a mid-pool concentrate.  The assay system 
employed cultures  of an anti--diphtheria  toxoid (anti-DT) response  whose media were re- 
placed every 12 hr. The concentrates  were obtained from pools  of an anti-BSA response,  as 
described  in the text.  Graph A. The untreated  reference  response.  Graph B. The response  to 
two medium changes containing  the combined early-late  anti-BSA pools concentrated 10- 
fold.  Graph C.  The  response  to two medium changes containing  the mid-anti-BSA pool,  also 
concentrated 10-fold.  Graph D. The response  to four  successive  medium changes containing 
the same mid-pool,  which was concentrated  only 2-fold.  The boxes above the graphs indicate 
by  their  height  the  pool  concentration,  and  by  their  length  the  duration  of  treatment. 
by pressure dialysis through ultra~ne membranes. The success of these prepara- 
tions eliminates the possibility that the inhibitory effect resulted from some 
reaction during dialysis occurring between the culture fluid and the sucrose or a 
contaminant of it (e.g. ribonuclease). 
In another experiment, complete inhibition was produced within 24 hr by a 
mid-pool concentrate (Fig. 9). Early and late pools from an anti-BSA experi- 
ment were combined and concentrated in an ultrafiltration cell (Amicon Corp., 
Lexington, Mass.) with a UM-2 Diaflo membrane, a synthetic polymeric mem- 
brane which retains molecules larger than 1000 mol wt. The mid-pool from the 1018  REGULATION  OF THE SECONDARY  ANTIBODY RESPONSE 
same anti-BSA experiment was similarly concentrated. Both concentrates were 
incorporated into different aliquots of medium, so that the nondialyzable com- 
ponents of each pool were present at a  10-fold concentration. The response of 
cultures producing tetanus toxoid responses are recorded in Fig. 9 for the 5 day 
period from day 10 to day 15; the medium of these cultures was replaced every 
12 hr. The response of the control group of cultures is shown in graph A  of 
Fig. 9. During this test period average titers between 1:600 and 1:1000 were 
produced every 12 hr. The cultures of graph B were treated with medium con- 
taining the early-late pool concentrate on day 12b and again on day 13a; there 
was  only a  gradual,  slight inhibition produced by this 24 hr exposure. How- 
ever, as seen in graph  C,  treatment of cultures with medium containing the 
mid-pool concentrate for the same two 12 hr intervals caused prompt inhibition, 
and the response was completely abolished within 24 hr after initiation of treat- 
ment with the mid-pool concentrate. In the same experiment, medium contain- 
ing the mid-pool at  only twice the  effective concentration produced a  more 
gradual inhibition of the response. 
Rapid Enhancement of Antibody Production by Actinomycin D  and Rapid 
Inhibition by Mid-pool Concentrates.--Although the search for an inhibitor in 
mid-pools was prompted by the enhancement of antibody synthesis by actino- 
mycin during the second week of the response, no direct evidence relating the 
enhancement by actinomycin D  with inhibition by mid-pool concentrates has 
been obtained. However, several experiments have shown a rise or fall in anti- 
body synthesis within several hours of the addition of the drug or the concen- 
trate, respectively, indicating a similar rapidity of action for these two opposite 
net effects. One such experiment is illustrated in Fig. 10. During the productive 
phase of this experiment, the medium in each tube was replaced every 2 hr; 
the period graphed in Fig. 10 covers only a 30 hr period during days 10 and 11. 
The five cultures whose average response is shown in graph A  received fresh 
medium with 0.0025/z~ actinomycin D  five times during a 10 hr period, indi- 
cated by the rectangle at the top of the graph. Within 2 hr the response showed 
enhancement, and within 6 hr more it reached a peak which was more than 
twice the pretreatment base line level. The response then began to fall despite 
another 2 hr of drug treatment, reached the base line level, and remained there 
for the next 12 hr. 
In this same experiment,  3 and during the same 10 hr period, medium con- 
taining  an  early anti-BSA pool was  added to three cultures,  whose average 
response is drawn in graph B  (Fig. 10). As in previous experiments, there was 
no effect on the base line response with this "early" medium. The three cultures 
The three concentrates tested in this experiment were pooled from the same anti-BSA 
experiment in the manner described above,  concentrated by lyophillzation, and  then ex- 
haustively dialyzed against normal saline. These pools were finally incorporated into new 
medium at a concentration of 4-fold. CHARLES  T. AMBROSE  1019 
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Fro.  10.  The precipitancy of enhancement by actinomycin D  and of inhibition by a mid- 
pool concentrate. The media of anti-tetanus toxoid (anti-TT) cultures were replaced every 2 
hr during the early productive phase, and their responses during days 10 and  11 are shown 
in this  figure.  During  a  10 hr period,  which entailed five medium changes,  cultures were 
treated with actinomycin D  (AD) or with one of the three anti-BSA pools.  This treatment 
interval is represented by the bar above each graph; the treatment is indicated by the data 
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whose response is shown in graph C received medium containing the mid-anti- 
BSA pool concentrate during the same 10 hr period. A sharp fall in the response 
occurred within 4 hr; the response eventually fell to less than 50% of the base 
line and remained at this reduced level for the next 14 hr. Finally, the three 
cultures of graph D received medium containing the late anti-BSA pool concen- 
trate during the same 10 hr period. This concentrate caused only moderate and 
gradual inhibition,  and the response returned eventually to the base line. 
DISCUSSION 
Enhancement of protein synthesis by actinomycin D  is a  phenomenon so 
contrary to the initially expected  effect that an isolated  report is often met 
with skepticism.  However,  this paradox has now been described  in so many 
different areas  of biology that collectively the papers  cannot be ignored.  In- 
deed, the biological systems exhibiting such enhancement are so varied that the 
phenomenon appears to be a general one, as illustrated by the following abbrevi- 
ated survey. 
In Bacillus sublilis low concentrations of actinomycin  D were found to double 
the rate  of induced penlcillinase  formation (7)  and to increase  ribonuclease 
synthesis by 80% (8). In rats given corficosteroid injections, the levels of several 
liver enzymes rise after a few hours, reach a plateau, and then fall to base line 
values 12 hr or so later (9). In such rats Garren et al. (6) observed that actino- 
mycin D injected several hours after the steroid increased tryptophan pyrrolase 
activity markedly above  that in rats given only the steroid.  Similarly,  rats 
treated with phenobarbital by injection show an increased  activity in their 
livers for aminopyrine demethylation; in such rats this activity is enhanced by 
acfinomycin D  treatment (10). There are now numerous examples of enzyme 
levels rising in animals following actinomycin D injection (11, 12) and in tissue 
cultures after addition of low levels of this drug (13-16). Even in the immuno- 
logical literature there is a surprising number of references to this phenomenon. 
Brown (17) and Wust and Hanna (18, 19)  studied the hemagglutinin re- 
sponse of mice treated by injection with sheep erythrocytes. Decreased  titers 
were produced when actinomycin was given after the sheep cell injection, but 
enhanced titers resulted under certain conditions of administration of the drug 
before the antigen. Brown observed  enhancement when about 150/zg  acfino- 
mycin C was given 72 hr before 0.2 ml 5 % sheep cells. Wnst and Hanna ob- 
tained enhancement when 12/zg actinomycin D  was injected 7 hr before  1.0 
ml 10% sheep cells. Speirs (20) also recorded similar increased antitoxin titers 
in mice given weekly injections  of tetanus toxoid plus 2.5/zg actinomycin D; 
higher doses of the drug were inhibitory. Both Smiley et al. (21) and Stavitsky 
and Gusdon (22) reported that antibody synthesis in rabbit lymph node cul- 
tures was occasionally enhanced by low levels of actinomycin D in the medium 
but was, of course, always depressed by higher levels. CHARLES  T.  AMBROSE  1021 
A perplexing  paper by Harris  (23) involves  plaque-forming cells in spleen 
cultures prepared from primed rabbits boosted with sheep erythrocytes 2-3 
days before death. High levels of actinomycin D  (10-100 #g/1.5 ml) or puro- 
mycin (50 #g/1.5 ml) added to the culture medium along with sheep erythro- 
cytes produced greatly increased plaque counts compared to controls cultured 
without either drug or without the sheep cell antigen. "The optimal concentra- 
tion  of actinomycin D  which stimulated  the appearance of specific PFC's 
[plaque-forming cells] in vitro was much higher than the level of the antibiotic 
required.., to inhibit DNA, RNA, and protein synthesis" (p. 680 of ref. 23). 
This and other features of Harris' study suggest to us that the increased plaque 
counts may have resulted from (a) weakening of the spleen cell membranes by 
the high levels of either drug, (b) lysis of these cells in the Jerne plates, and (c) 
release of preformed antibody. 
The common explanations  of enhancement of protein synthesis by actino- 
mycin so far proposed will be reviewed in detail elsewhere.  4 Briefly they suggest 
(a) a diversion of intraceilular substrates from the synthetic pathway of these 
proteins selectively inhibited to the polysomes of those r~ot inhibited by critical 
levels of this drug (7),  (b) a selective inhibition by actinomycin of certain deg- 
radative enzymes involved in protein turnover (15, 24, 25), or (c) a  selective 
inhibition of a normally occurring "cytoplasmic repressor" affecting transla- 
tion (6, 26, 27). The enhancement in antibody synthesis observed in the lymph 
node cultures treated with low levels  of actinomycin in  the present study, 
coupled with  the recovery of an  antibody-inhibitory material from culture 
media, favors the third theory. Indeed, the paper by Garren et al. (6) prompted 
our search for an inhibitor. 
Translational "Repressor" Theory.--This  explanation for actinomycin D  en- 
hancement was originally proposed by McAuslan in 1963 (26), and independ- 
entiy soon afterward by two other groups of investigators (6, 27).  Poxvirus 
infection of HeLa ceils causes a marked increase in thymidine kinase activity 
for 6 hr; treatment of these cultures 2-4 hr after infection with actinomycin D 
allows kinase synthesis to continue for 18 hr. McAnslan concluded that "repres- 
sion" of thymidine kinase synthesis normally occurs 6 hr after virus infection, 
and that actinomycin D prevents this "repression." Similarly, in 1964, Garren 
at al.  (6) proposed that several hours after steroid-induced enzyme synthesis 
begins in rat liver there appears a "repressor" which prevents further enzyme 
synthesis. This  "repressor"  acts by inhibiting the  function  of  the  existing 
mRNA, has a rapid turnover rate, and is itself very sensitive to actinomycin D. 
Tomkins and coworkers (28) have since duplicated these studies in a hepatoma- 
culture line and extended their conclusions. Also, in 1964 Scarano et al.  (27) 
postulated inhibition by actinomycin of a  "specific  repressor" to explain the 
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following observation. During embryonic development of the sea urchin there 
normally occurs a fall in the level of deoxycytidylate aminohydrolase, an en- 
zyme involved in DNA synthesis. Actinomycin D  treatment not only prevents 
this fall but increases the enzyme level above that in the unfertilized egg. 
The data presented above raise many questions, but only two can be dis- 
cussed at any length in this paper: (a) What is the correlation between  anti- 
body synthesis augmented by actinomycin and the inhibitorymaterial recovered 
from used culture medium? (b) What relationship does this antibody-inhibitory 
material have to certain other factors thought to regulate the immune response? 
Antibody-Inhibitory Material.--This inhibitory material can be related to the 
postulated "repressor" substance of these three groups of investigators primarily 
because the period of AIM production in our cultures (days 6-12, or the "mid- 
pool" period)  coincides with the period of potential actinomycin D  enhance- 
ment (days 6-15). Also lymph node cultures stimulated to produce a secondary 
response in vitro yield a potent inhibitory mid-pool concentrate, while other 
cultures prepared from the same source of fragments, but not stimulated in 
vitro, produce no antibody and yield no AIM. Thus AIM is produced as a con- 
sequence of and concurrent with the immune response. AIM is not, therefore, 
a property of all used culture medium. Finally, in kinetic experiments enhanced 
antibody synthesis appears  within 2 hr,  of adding actinomycin D,  while in- 
hibition is evident within 4 hr of adding a  potent mid-pool concentrate (see 
Fig. 10).  Since AIM is a macromolecule, it may enter cells more slowly than 
does actinomycin D  (mol wt 1254).  Thus these two opposite manifestations 
develop with a similar speed, which is at least consistent with their representing 
the same phenomenon. 
From these slim pieces of information we can begin to characterize AIM. 
The molecular weight of the inhibitor is above 10,000, since it is retained by 
dialysis tubing  (29).  The  inhibitor is  not  specific  antibody,  since  mid-pool 
concentrates from either anti-BSA or anti-ovalbumin  responses inhibit anti- 
tetanus and anti-diphtheria response. The inhibitor is probably not a v-globulin, 
since there are high titers of this protein in the late pool concentrates, which 
produce little or no inhibition (see Fig. 8 A and E). Further chemical characteri- 
zation has been delayed for want of an assay system less consumptive of AIM 
than the one depicted in Fig. 8. A more economical assay appears possible with 
the  present  observation  that  prompt  inhibition  is  produced  when  AIM  is 
added for only a short time during the productive phase (Fig. 10). 
This preliminary information raises several obvious questions about AIM. 
We have yet to determine whether or not it is  active during the inductive 
phase. In the earliest experiments (exemplified by Fig. 8 D), AIM was present 
throughout days 0-12, which includes the early productive phase in vitro. Also 
nothing is known about the stability of AIM in culture, an important considera- 
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inductive phase. An even more important question concerns the apparent lack 
of specificity of AIM, as concluded from the observation that mid-pool concen- 
trates  of either  anti-BSA  or  anti-ovalbumin  experiments inhibit both anti- 
tetanus toxoid and anti-diphtheria  toxoid responses.  Two reports in the im- 
munological  literature  support the  existence of such a  nonspecific  antibody- 
inhibiting material produced during the immune response. These are reports 
dealing  primarily with antigenic competition. 
Other Postulated Mechanisms Controlling the Immune  Response: Antigenic 
Competition.--Wust mad Hanna (18, 19) studied the impact of actinomycin D 
on the antibody response in mice treated  by successive injections with  two 
"immunologically unrelated"  antigens:  sheep  erythrocytes and  rat  erythm- 
cytes. Injection of either antigen  alone in control mice produced comparable 
hemagglutinin  responses,  first  detectable  after  a  latent  period  of  1-2  days. 
Their observations germane to our discussion  are summarized below. 
1.  Mice treated with actinomycin D  7 hr before injection of sheep erythro- 
cytes showed (a)  a 3-day latent  period, (b) antibody response rates "compa- 
rable" to those of control mice, but (c) "significantly higher" peak titers than 
those of control mice. Having observed that large pyronin-staining cells in the 
spleen survived the drug's cytotoxic effect, Wust and Hanna speculated that 
these ceils were "stimulated by residual antigen" and rapidly repopulated the 
splenic nodules "because of increased volume.., available after clearance of 
ceil debris." 
2.  Mice treated with actinomycin D  7 hr before injection of rat erythrocytes 
showed (a) a latent period of 6-7 days, (b) normal rates of synthesis, but (c) no 
peak titers above those of control mice. The differences  between observations 
2 and 1 were thought due to rat erythrocytes' being antigeuically less foreign 
for mice than are sheep erythrocytes. 
3.  Injection of sheep erythrocytes followed 2 days later by rat erythrocytes 
resulted in a normal anti-S-RBC response but no anti-R-RBC response.  De- 
laying the R-RBC injection until 6 days after the S-RBC stimulation allowed 
a subnormal anti-R-RBC response,  and delaying it until 10 days permitted a 
normal anti-R-RBC response.  Wust and Hanna argued that the anti-S-RBC 
response produced a 6 day refractory period for the R-RBC because the first 
antigen "committed most of the potentially competent ceils" and pre-empted 
a response to the second antigen over the next 6 days. 
4.  In contrast to observation 3, when the reciprocal sequence of injections 
was  tested,  there  was  a  normal  response  to  the  second  antigen  (S-RBC). 
Presumably, the less foreign R-RBC injected first did not completely commit 
all the potentially competent cells. 
5.  In mice treated  with successive injections of actinomycin D,  S-RBC 7 
hours later, and R-RBC 2 days later, there were normal responses to both anti- 
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by prior treatment with actinomycin D. Wust and Hanna reasoned that  the 
drug interfered with the cells' becoming "totally committed to the first anti- 
gen." 
The concept of AIM can provide an alternative single explanation for Wust 
and Hanna's observations enumerated above. In mice treated with actinomycin 
D  7 hr before antigen stimulation, the delay in the response obviously involves 
several factors: the cytotoxidty of the drug, its initially high but soon falling 
intracellular  level,  the recovery rate of the immunocompetent cells,  and  the 
antigen's relative immunogenidty. The enhanced anti-S-RBC response follow- 
ing treatment with actinomycin D  (see observation 1) resulted from a fortui- 
tously optimal residual level of actinomycin D  in the cells at the time AIM 
synthesis would have begun. In the mice treated with actinomycin D and R-RBC 
(see observation 2), the response was not enhanced because it developed 3-4 
days later than in observation 1 and too few molecules of the drug were present 
in the anti-R-RBC responding cells at the time of their AIM synthesis. Since 
AIM is secreted during the early productive phase into tissue culture medium, 
it must also be released into splenic nodules in vivo. Thus the refractory period 
for R-RBC described under observation 3 reflected production of AIM by those 
cells responding to the first antigen injected, S-RBC. In the reciprocal injection 
sequence (see observation 4), the slightly slower anti-R-RBC response did not 
produce enough AIM soon enough to impede the second response to the more 
immunogenic S-RBC. In mice treated sequentially with actinomydn D, S-RBC, 
and R-RBC (see observation 5), the drug reduced the synthesis of AIM during 
the anti-S-RBC response; this had the dual effect of augmenting the anti-S- 
RBC response and permitting an otherwise inhibited anti-R-RBC response. 
In a dearly reasoned paper Radovich and Talmage (30) examined antigenic 
competition between sheep and horse erythrocytes injected sequentially into 
mice. They assayed for hemolytic plaque-forming cells in mouse spleen by the 
method of Jerne and Nordin.  In their normal mice the spleen plaque count 
reached a peak 4-5 days after injection of either antigen and then rapidly de- 
clined. Simultaneous injection of both antigens caused "no significant  inhibition 
of either response," but the response to the second antigen was reduced when it 
was injected at various times after the first antigen.  Maximal reduction (13- 
fold)  occurred when an interval of 4 days separated the two injections. The 
authors  doubted  "that  the  phenomenon  of antigenic  competition  is  in  fact 
competition for anything." For this to be so they would have expected maximal 
competition when the two antigens were injected simultaneously. In adoptive 
transfer  experiments  they found a  greater reduction in the second antigen's 
response  when 50  x  106 spleen cells were transferred to sublethally irradiated 
recipient mice than when only 10  x  106 cells were injected. From these data 
they hypothesized that a humoral factor was produced during the first response 
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antigen." This is a clear statement of the "repressor"  hypothesis, which our 
data support. 
Cell-Extra~  InhiMtors  of Antibody S~thesis.--The  immune response has 
been depressed in a  nlmals given extracts of various organs by injection (31), 
isolated serum fractious (e.g. bovine y-globulin)  (32), and chemically derived 
ribonudease complexes (33). It is doubtful that the substances listed above are 
identical with or similar to the inhibitory material found in our tissue culture 
media (AIM), since these substances  are inhibitory only when injected into a 
test animal 10-24 hr before the antigen. In contrast, AIM is dearly inhibitory 
when  added  to  cultures during  the  early productive phase.  Because  these 
various protein substances  must precede the antigen, some authors (34) have 
speculated  that their inhibitory effect may be due partly to antigenic  com- 
petition. If this is true, these substances are indirectly related to AIM by virtue 
of eliciting its production. 
Another reason for doubting an identity or similarity to AIM is that these 
substances  were not derived from immunized a,  lmals. Thompson and Fishel 
(31)  prepared  their extracts from spleen  and thymus but  did not compare 
extracts from normal and immune anLmals. Such a comparison  was made by 
Gurvich et al. (35), who obtained extracts from several rabbit organs: normal 
spleen and liver and immunized spleen. The extracts were added to suspension 
cultures of rabbit spleen cells in the early productive phase.  Incorporation of 
labeled amino acids into newly synthesized antibody was depressed by the liver 
and normal spleen extracts but was slightly stimulated by the spleen extracts 
from immunized rabbits. The observations  of Gurvich et al.  involve  factors 
different from those under study in this report, since even normal liver extracts 
inhibited their  antibody system. In  contrast,  the present  investigation has 
shown production of an inhibitor during only a certain period of the immune 
response, and never with nonresponding lymph node cultures. 
Interferon  and  Antibody  Synthesis.--In  an article entitled "The Effect of 
Newcastle Disease  Virus  on Antibody Synthesis," Medzon and Vas  (36) re- 
ported that this virus not only inhibited antibody formation in immune rabbit 
spleen  cultures but also produced a  general  arrest of protein synthesis.  The 
title of this paper in particular raised the question whether interferon could in- 
hibit the immune response. 
De Somer et al. (37) found that poliovirus-neutralizing  antibody fiters were 
reduced in rats or mice when Sindbis virus or Escherichia coli was injected 24 hr 
before poliovirus, but not when either was given 48 hr after the poliovirus. The 
authors stated that Sindbis virus was a more potent interferon inducer  than 
E. toll, but that the virus was the less effective inhibitor. Indeed, small amounts 
of E. coli insufficient to induce demonstrable interferon could still inhibit anti- 
body synthesis.  These data may well represent  another instance of antigenic 
competition and thus, possibly, of AIM involvement. De Somer et al. were also 1026  REGULATION  OF THE SECONDARY  ANTIBODY  RESPONSE 
unsuccessful in  depressing  antibody synthesis by injecting  exogenously pro- 
duced interferon into animals.  A similar  set of negative experiments has been 
reported (38). 
Mazzur and Paucker (39) preserved mouse spleen cells in cultures by incubat- 
ing  spleen suspensions  on rabbit kidney feeder layers. During this incubation 
the cells could be exposed to interferon,  then shaken off the feeder layer, and 
assayed for antibody production in one of three immune systems, depending 
on how the donor mice were first immunized--by the Jerne plaque method or 
by adoptive transfer  of spleen  cells  from mice given  sheep  erythrocytes or 
Shigdla dysenleriae. In none of the systems they tested did high levels of inter- 
feron (up to 600 units) exert any inhibitory effect. 
Analogous experiments, using the present culture system, also  exhibited no 
inhibitory  effect by interferon.  From  Sindbis-infected rabbits  sera were ob- 
tained  which  contained  high  titers  of interferon;  they failed  to  inhibit  the 
productive phase of the secondary response in vitro3 
S17u~ARY 
Two opposite effects of actinomycin D  on  antibody synthesis have  been 
studied in organ cultures of rabbit lymph node fragments. These cultures were 
prepared  from previously primed  rabbits and  stimulated  with  antigen(s)  on 
day 0 to yield a secondary response,  whose inductive phase extended to about 
day 9 and whose productive phase may last for several months in the serum- 
free medium described here. 
Concentrations  of  actinomycin  D  above 0.01  /~  (0.012  /~g/ml)  produce 
inhibition of antibody synthesis during both phases of the response.  However, 
antibody synthesis is about 10 times more sensitive to inhibition by this drug 
when it is added during the inductive phase than during the productive phase. 
During the latter phase, synthesis is more rapidly terminated as the drug level 
approaches 10/~ (12.5/~g/ml). At this level the 50% synthesis time is about 
2.8 hr,  which is identical with that found when 5-10/~ puromycin is added 
to the medium of parallel cultures. 
Transient  enhancement  of antibody synthesis is frequently produced by a 
brief exposure to low levels  of actinomycin D  (generally less than 0.01 /~r). 
Enhancement appears in precise temporal association with actinomycin pulses 
added for 2 days or less only between days 6 and 16. This apparent enhance- 
ment of antibody synthesis resembles the increased enzyme synthesis described 
by Garren et al.  (6)  and led to a  search for an antibody-inhibitory material 
(AIM)  whose synthesis might  be stopped preferentially by low levels  of the 
drug. 
Stimulated lymph node cultures produce between days 6 and 15 a nondialyz- 
S. Stone and C. T. Ambrose. Unpublished observations. CHARLES T.  AMBROSE  1027 
able material which inhibits antibody synthesis during the productive phase of 
heterologous antigen-antibody culture systems. Just as enhancement with low 
levels of actinomycin D  appears within 2 hr after the drug has been added to 
cultures,  so inhibition  occurs within  4  hr  of adding  AIM  to  cultures  during 
their productive phase. These observations suggest that AIM is analogous to 
the translational "repressor" postulated by Garren et al. (6). AIM has relevance 
in two areas of immunology: (a) it may be the explanation for many examples 
of antigenic competition, and (b) it may represent a normal control mechanism 
for the productive phase. 
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